Duration of exposure, a neglected factor in chemoprevention trials

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 11 I, 2005, Pages 2465-2466

  Fontham, Elizabeth T H ^a,b   Correa, Pelayo ^b   Mera, Robertino ^b   Bravo, Luis Eduardo ^c   Bravo, Juan Carlos ^c   Piazuelo, Maria Blanca ^b   Camargo, M Constanza ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARCINOGEN;

BACTERIAL VIRULENCE; CANCER DIAGNOSIS; CANCER PREVENTION; CARCINOGENESIS; CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; NOTE; OUTCOMES RESEARCH; PRECANCER; PRIORITY JOURNAL; PUBLICATION; TREATMENT OUTCOME;

CHEMOPREVENTION; CLINICAL TRIALS; ENVIRONMENTAL EXPOSURE; FOLLOW-UP STUDIES; HUMANS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 28644437065     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0518     Document Type: Note

References (7)

1. Note from the editors. Cancer Epidemiol Biomarkers Prev 2005;14:1359.
2. Meyskens FL, Jr., Szabo E. Diet and cancer: the disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev 2005;14:1366-9.
3. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Vol. 61. Lyon (France): IARC; 1994. p. 177-240.
4. Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut. Epub 2005 Jun 28.
5. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978;32:303-13.
6. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8.
7. Correa P, van Doorn LJ, Bravo JC, et al. Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients. Am J Gastroenterol 2000;95:564-6.